Document:

First Amendment to 1997 Long Term Incentive Compensation Plan

 Exhibit 10.32 
  
 AMENDMENT 
 TO

 AMENDED AND RESTATED 1997 LONG TERM INCENTIVE COMPENSATION PLAN 
 EFFECTIVE NOVEMBER 15, 2000 
  
 The Caremark Rx, Inc. Amended and Restated 1997 Long Term Incentive Compensation Plan (the “Plan”) is hereby amended as follows: 
  
 1. Amendment Regarding Transferability of Nonqualified Stock Options. Section 6.10(b) of the Plan is hereby amended by deleting Section 6.10(b)
in its entirety and substituting the following new Section 6.10(b) therefor: 
  
 (b) NONQUALIFIED STOCK OPTIONS. No NQSO granted under the Plan may be sold, transferred, pledged, assigned or otherwise alienated or
hypothecated, other than by will or by the laws of descent and distribution. Notwithstanding the foregoing, to the extent not prohibited by any statute, rule or regulation applicable to the Plan, the Options, or the registration with the Securities
and Exchange Commission of the Shares to be issued upon exercise of the Options, the Committee may, in its discretion, authorize all or a portion of NQSOs granted to a Participant to be on terms which permit transfer by such Participant to
(i) Immediate Family Members, (ii) a trust or trusts for the exclusive benefit of such Immediate Family Members, or (iii) a partnership in which such Immediate Family Members are the only partners, provided that (A) the Award
Agreement pursuant to which such Options are granted must be approved by the Committee, and must expressly provide for transferability in a manner consistent with this Section, and (B) subsequent transfers of transferred Options shall be
prohibited except those by will or the laws of descent and distribution. Following transfer, any such Options shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer, provided that for purposes
of this Plan, the term “Participant” shall be deemed to refer to the transferee. The events of termination of employment shall continue to be applied with respect to the original Participant, following which the Options shall be

  

 1 

 exercisable by the transferee only to the extent, and for the periods specified in this
Section 6.10. Notwithstanding the foregoing, should the Committee provide that Options granted be transferable, the Company by such action incurs no obligation to notify or otherwise provide notice to a transferee of early termination of the
Option. In the event of a transfer, as set forth above, the original Participant is and will remain subject to and responsible for any applicable withholding taxes upon the exercise of such Options. 
  
 2. Effective Date. The effective date of this Amendment shall be
November 15, 2000. 
  
 3. Miscellaneous. 
  
 (a) Capitalized terms not otherwise defined herein shall have the meanings
given them in the Plan. 
  
 (b) Except as specifically amended
hereby, the Plan shall remain in full force and effect. 
  
 IN
WITNESS WHEREOF, the Company has caused this Amendment to the Caremark Rx, Inc. Amended and Restated 1997 Long Term Incentive Compensation Plan to be executed as of the Effective Date. 
  

	
	 CAREMARK RX, INC.

	 Sara J. Finley, Corporate Secretary

  

 2Second Amendment to 1997 Long Term Incentive Compensation Plan

 Exhibit 10.33 
  
 SECOND AMENDMENT 
 TO THE 
 CAREMARK RX, INC. 1997 STOCK INCENTIVE PLAN 
 (FORMERLY THE AMENDED & RESTATED MEDPARTNERS, INC. 
 1997 LONG TERM INCENTIVE COMPENSATION PLAN)

  
 This Second Amendment to the Caremark Rx, Inc. 1997 Stock
Incentive Plan (formerly the Amended & Restated Medpartners, Inc. 1997 Long Term Incentive Compensation Plan) (the “Plan”) to be effective as of January 12, 2001. 
  
 WITNESSETH: 
  
 WHEREAS, Caremark Rx, Inc. (the “Company”) currently sponsors and maintains the Caremark Rx, Inc. 1997 Stock Incentive Plan (formerly the
Amended & Restated Medpartners, Inc. 1997 Long Term Incentive Compensation Plan) (the “Plan”); and 
  
 WHEREAS, Section 13.1 of the Plan grants the Compensation Committee of the Board the power at any time to amend the Plan, and the Compensation
Committee now wishes to amend the Plan to modify the vesting provisions for options granted under the Plan on and after January 12, 2001; 
  
 NOW, THEREFORE, the Plan is hereby amended as indicated below: 
  
 1. 
  
 Section 6.4 of the Plan is amended effective as of January 12, 2001, to read as follows: 
  
 6.4 VESTING OF OPTIONS. Except as provided by the Committee
in the applicable Award Agreement, Options shall vest and become exercisable as follows: 
  
 (a) 34% of the Options shall vest on the date such options are granted; 
  
 (b) 33% of the Options granted shall vest on each of the 
  
 Second Amendment to the 
 Caremark Rx, Inc. 1997 Stock Incentive Plan 
 Page 1 

 first anniversary and second anniversary of the date such Options are granted; provided, however, that
for Options granted prior to January 12, 2001, if during the first year after the date such Options are granted, the stock price of the Shares closes at or above $12.00 (or such other price as determined by the Committee and set forth in the
applicable Award Agreement) for any twenty (20) out of thirty (30) consecutive trading days, the 33% of the Options due to vest on the first anniversary of the date such Options are granted shall vest immediately at the end of such 20th
day, and provided, however, that for Stock Options granted prior to January 12, 2001, if during the second year after the date such Options are granted, the stock price of the Shares closes at or above $18.00 (or such other price as determined
by the Committee and set forth in the applicable Award Agreement) for any twenty (20) out of thirty (30) consecutive trading days, the 33% of the Options due to vest on the second anniversary of the date such Options are granted shall vest
immediately at the end of such 20th day. 
  
 2. 
  
 The name of the Plan is changed effective as of January 12, 2001 from
the Amended & Restated Medpartners, Inc. 1997 Long Term Incentive Compensation Plan to the Caremark Rx, Inc. 1997 Stock Incentive Plan. All references in any Company documents to the Amended & Restated Medpartners, Inc. 1997 Long
Term Incentive Compensation Plan shall, after January 12, 2001, be a reference to the Caremark Rx, Inc. 1997 Stock Incentive Plan. 
  
 3. 
  
 All other provisions of the Plan not inconsistent herewith are hereby confirmed and ratified. 
  
 Approved by the Board of Directors by resolutions on January 12, 2001.

  
 Second Amendment to the 
 Caremark Rx, Inc. 1997 Stock Incentive Plan 
 Page 2Amended and Restated 1998 Employee Stock Option Plan

 Exhibit 10.34 
  
 CAREMARK RX, INC. 
  
 1998 EMPLOYEE STOCK OPTION PLAN 
  
 ARTICLE 1. ESTABLISHMENT, OBJECTIVES AND DURATION 
  
 1.1 ESTABLISHMENT OF THE PLAN. Caremark Rx, Inc., a Delaware corporation (hereinafter referred to as the “Company”), hereby
establishes a compensation plan to be known as the “Caremark Rx, Inc. 1998 Employee Stock Option Plan” (hereinafter referred to as the “Plan”), as set forth in this document. The Plan permits the grant of Options and is intended
to fit within the exception to the New York Stock Exchange’s shareholder approval requirement for broadly-based stock option plans set forth in section 312.03(a)(2) of the New York Stock Exchange Listed Company Manual as of the date hereof.

  
 The Plan shall become effective as of August 6, 1998 (the “Effective
Date”) and shall remain in effect as provided in Section 1.3 hereof. 
  
 1.2 OBJECTIVES OF THE PLAN. The objectives of the Plan are to optimize the profitability and growth of the Company through the use of stock options, which are consistent with the Company’s objectives and which link the interests of
Participants to those of the Company’s stockholders; to provide Participants with an inducement for excellence in individual performance; and to promote teamwork among Participants. 
  
 The Plan is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of
Participants who make significant contributions to the Company’s success and to allow Participants to share in the success of the Company. 
  
 1.3 DURATION OF THE PLAN. The Plan shall commence on the Effective Date, as described in Section 1.1 hereof, and shall remain in effect, subject to the right of the
Board of Directors or the Committee to amend or terminate the Plan at any time pursuant to Article 11 hereof, until all Shares subject to it shall have been purchased or acquired according to the Plan’s provisions. 
  

 1 

 ARTICLE 2. DEFINITIONS 
  
 Whenever used in the Plan, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter
of the word shall be capitalized: 
  
 2.1
“AFFILIATE” means a “parent corporation” or “subsidiary corporation” as defined in Section 424 of the Code. 
  
 2.2 “AWARD” means, individually or collectively, a grant under this Plan of Options. 
  
 2.3 “AWARD AGREEMENT” means either (i) an agreement entered into by the
Company and each Participant setting forth the terms and provisions applicable to Awards granted under this Plan or (ii) a certificate executed by the Company and delivered to the Participant evidencing and setting forth the terms and
provisions applicable to Awards granted under this Plan. 
  
 2.4 “BENEFICIAL
OWNER” OR “BENEFICIAL OWNERSHIP” shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act. 
  
 2.5 “BOARD” OR “BOARD OF DIRECTORS” means the Board of Directors of the Company.

  
 2.6 “CAUSE” shall be determined by the Committee, exercising good
faith and reasonable judgment, and shall mean the occurrence of any one or more of the following: 
  
 (a) The willful and continued failure by the Participant to substantially perform his duties (other than any such failure resulting from the
Participant’s Disability) after a written demand for substantial performance is delivered by the Committee to the Participant that specifically identifies the manner in which the Committee believes that the Participant has not substantially
performed his duties, and the Participant has failed to remedy the situation within 30 calendar days of receiving such notice; or 
  

 2 

 (b) The Participant’s conviction for committing an act of fraud, embezzlement, theft or another act
constituting a felony; or 
  
 (c) The willful engaging by the
Participant in gross misconduct materially and demonstrably injurious to the Company, as determined by the Committee. However, no act or failure to act on the Participant’s part shall be considered “willful” unless done, or omitted to
be done, by the Participant not in good faith and without reasonable belief that his action or omission was in the best interest of the Company. 
  
 2.7 “CHANGE IN CONTROL” of the Company shall be deemed to have occurred as of the first day that any one or more of the following conditions shall have been
satisfied: 
  
 (a) The acquisition by any Person of Beneficial
Ownership of 20% or more of either (i) the then outstanding shares of Common Stock of the Company, or (ii) the combined voting power of the outstanding voting securities of the Company entitled to vote generally in the selection of
Directors; provided, however, that for purposes of this subsection, the following transactions shall not constitute a Change of Control: (A) any acquisition directly from the Company through a public offering of shares of Common Stock of the
Company, (B) any acquisition by the Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company, or (D) any acquisition by any
corporation pursuant to a transaction which complies with clauses (i), (ii) and (iii) of subsection (c) below; 
  
 (b) The cessation, for any reason, of the individuals who constitute the Company’s Board of Directors as of the date hereof (“Incumbent
Board”) to constitute at least a majority of the Company’s Board of Directors; provided, however, that any individual becoming a Director following the date hereof whose election, or nomination for election by the Company’s
stockholders, was approved by a vote of at least a majority of the Directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual
whose initial assumption of office occurs because of an actual or threatened election contest with respect to the election or removal of Directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other
than the Company’s Board of Directors; 
  

 3 

 (c) The consummation of a reorganization, merger or consolidation or sale or other disposition of all or
substantially all of the assets of the Company (“Business Combination”) unless, following such Business Combination, (i) all or substantially all of the individuals and entities who were the Beneficial Owners, respectively, of the
outstanding shares of Common Stock of the Company and the outstanding voting securities of the Company immediately before such Business Combination beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares
of Common Stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of Directors, as the case may be, of the Company resulting from such Business Combination (including, without
limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership
immediately before such Business Combination of the outstanding shares of Common Stock and the outstanding voting securities of the Company, as the case may be; (ii) no party (excluding any corporation resulting from such Business Combination
or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, the then outstanding shares of common stock of the
corporation resulting from such Business Combination or the combined voting power of the then outstanding voting securities of such corporation except to the extent that such ownership existed before the Business Combination; and (iii) at least
a majority of the members of the board of directors of the corporation resulting from such Business Combination were members of the Company’s Board of Directors at the time of the execution of the initial agreement, or of the action of the
Company’s Board of Directors, providing for such Business Combination; 
  
 (d) The approval by the stockholders of the Company of a complete liquidation or dissolution of the Company; or 
  
 (e) Any other condition or event (i) that the Committee determines to be a “Change in Control” within the meaning of this Section 2.7
and (ii) that is set forth as a supplement to this Section 2.7 in the Award Agreement. 
  

 4 

 2.8 “CODE” means the Internal Revenue Code of 1986, as amended from time to
time. 
  
 2.9 “COMMITTEE” means the Compensation Committee of the Board,
as specified in Article 3 herein, or such other Committee appointed by the Board to administer the Plan with respect to grants of Awards. 
  
 2.10 “COMMON STOCK” means Caremark Rx, Inc. common stock, $.001 par value. 
  
 2.11 “COMPANY” means Caremark Rx, Inc., and also means any corporation of which a
majority of the voting capital stock is owned directly or indirectly by Caremark Rx, Inc. or by any of its Subsidiaries, and any other corporation designated by the Committee as being a Company hereunder (but only during the period of such ownership
or designation). 
  
 2.12 “DIRECTOR”
means any individual who is a member of the Board of Directors of Caremark Rx, Inc. 
  
 2.13 “DISABILITY”, as applied to a Participant, means that the Participant (a) has established to the satisfaction of the Committee that the Participant is unable to engage in any substantial gainful activity by reason of any
medically determinable physical or mental impairment which can be expected to last for a continuous period of not less than 12 months (all within the meaning of Section 22(e)(3) of the Code), and (b) has satisfied any requirement imposed
by the Committee in regard to evidence of such disability. 
  
 2.14 “EFFECTIVE DATE” shall have the meaning ascribed to such term in Section 1.1 hereof. 
  
 2.15 “ELIGIBLE PERSON” shall mean all Employees, Directors or officers of the Company or any affiliate, the majority of whom are neither officers nor Directors
of the Company. 
  

 5 

 2.16 “EMPLOYEE” means any officer or employee of the Company. 
  
 2.17 “EXCHANGE ACT” means the Securities Exchange Act of 1934, as amended from time
to time, or any successor act thereto. 
  
 2.18 “FAIR MARKET VALUE”
Except as otherwise determined by the Committee, the “Fair Market Value” of a share of Common Stock as of any date shall be equal to the closing sale price of a share of Common Stock as reported on The National Association of Securities
Dealers’ New York Stock Exchange Composite Reporting Tape (or if the Common Stock is not traded on the New York Stock Exchange, the closing sale price on the exchange on which it is traded or as reported by an applicable automated quotation
system) (the “Composite Tape”), on the applicable date or, if no sales of Common Stock are reported on such date, the closing sale price of a share of Common Stock on the date the Common Stock was last reported on the Composite Tape (or
such other exchange or automated quotation system, if applicable). 
  
 2.19 “IMMEDIATE FAMILY MEMBERS” means the spouse, children and grandchildren of a Participant. 
  
 2.20 “INSIDER” shall mean an individual who is, on the relevant date, a Director, a 10% Beneficial Owner of any class of the Company’s equity securities
that is registered pursuant to Section 12 of the Exchange Act or an officer of the Company, as defined under Section 16 of the Exchange Act and as determined by the Board of Directors from time to time. 
  
 2.21 “NONEMPLOYEE DIRECTOR” means an individual who is a member of the Board of
Directors of the Company but who is not an Employee of the Company. 
  
 2.22
“OPTION” means an option to purchase Shares granted under Article 6 herein and which is not intended to meet the requirements of Code Section 422. 
  
 2.23 “OPTION PRICE” means the price at which a Share may be purchased by a Participant pursuant
to an Option. 
  
 2.24 “PARTICIPANT”
means an Eligible Person who has outstanding an Award granted under the Plan. 
  

 6 

 2.25 “PERSON” shall have the meaning ascribed to such term in Section 3(a) (9) of the Exchange Act
and used in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) thereof. 
  
 2.26 “PLAN” means the Caremark Rx, Inc. 1998 Employee Stock Option Plan. 
  
 2.27 “SHARES” means Common Stock of Caremark Rx,
Inc., par value $.001 per share. 
  
 2.28 “SUBSIDIARY” means any
corporation, partnership, joint venture or other entity in which the Company has a majority voting interest. 
  
 ARTICLE 3. ADMINISTRATION 
  
 3.1 THE COMMITTEE. The Plan shall be administered by the Committee, or by any other committee appointed by the Board, which Committee shall consist solely of two or more
“Nonemployee Directors” within the meaning of Rule 16b-3 under the Exchange Act, or any successor provision. The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board of
Directors. 
  
 3.2 AUTHORITY OF THE COMMITTEE. Except as limited by law or by the
Certificate of Incorporation or Bylaws of the Company, and subject to the provisions herein, the Committee shall have full power to select Participants who shall participate in the Plan; determine the sizes and types of Awards; determine the terms
and conditions of Awards in a manner not inconsistent with the Plan; construe and interpret the Plan and any agreement or instrument entered into under the Plan as they apply to Participants; establish, amend or waive rules and regulations for the
Plan’s administration as they apply to Participants; alter, amend, suspend or terminate the Plan in whole or in part; and (subject to the provisions of Article 11 herein) amend the terms and conditions of any outstanding Award to the extent
such terms and conditions are within the discretion of the Committee as provided in the Plan. As permitted by law, the Committee may delegate its authority as identified herein. 
  
 3.3 DECISIONS BINDING. All determinations and decisions made by the 
  

 7 

 Committee pursuant to the provisions of the Plan and all related orders and resolutions of the Board shall be final,
conclusive and binding on all persons, including the Company, its stockholders, Employees, Participants and their estates and beneficiaries. 
  
 3.4 COSTS OF PLAN. The costs and expenses incurred in the operation and administration of the Plan shall be borne by the Company. 
  
 ARTICLE 4. SHARES SUBJECT TO THE PLAN AND MAXIMUM AWARDS

  
 4.1 NUMBER OF SHARES AVAILABLE FOR GRANTS. Subject to adjustment as provided
in Section 4.2 herein, the number of Shares hereby reserved for issuance to Participants under the Plan shall be Seven Million (7,000,000). 
  
 Shares issued upon exercise of Options under the Plan may be either authorized but unissued Shares or Shares reacquired by the Company. If, on or prior to the termination
of the Plan, an Award granted thereunder expires or is terminated for any reason without having been exercised or vested in full, the unpurchased or unvested Shares covered thereby will again become available for the grant of Awards under the Plan.
Shares covered by Options surrendered in connection with the exercise of other Options shall not be deemed to have been exercised and shall again become available for the grant of awards under the Plan. 
  
 4.2 ADJUSTMENTS IN AUTHORIZED SHARES. In the event of any change in corporate capitalization,
such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property (excluding cash dividends) of the Company, any reorganization (whether or not such
reorganization comes within the definition of such term in Code Section 368) or any partial or complete liquidation of the Company, an adjustment shall be made in the number and class of Shares which may be delivered under Section 4.1, in
the number and class of and/or price of Shares subject to outstanding Awards granted under the Plan, and in the Award limits set forth in Section 4.1, as may be determined to be appropriate and equitable by the Committee, in its sole
discretion, to prevent dilution or enlargement of rights; provided, however, that the number of Shares subject to any Award shall always be a whole number. 
  

 8 

 ARTICLE 5. ELIGIBILITY AND PARTICIPATION 
  
 5.1 ELIGIBILITY. All Eligible Persons are eligible to
participate in this Plan. 
  
 5.2 ACTUAL PARTICIPATION. Subject to the provisions
of the Plan, the Committee may, from time to time, select from all Eligible Persons, those to whom Awards shall be granted and shall determine the nature and amount of each Award. 
  
 ARTICLE 6. STOCK OPTIONS 
  
 6.1 GRANT OF OPTIONS. Subject to the terms and provisions of the Plan, Options may be granted to Eligible Persons in such number, and upon
such terms, and at any time and from time to time as shall be determined by the Committee. 
  
 6.2 AWARD AGREEMENT. Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the duration of the Option, the number of Shares to which the Option pertains, and such other
provisions as the Committee shall determine. The Award Agreement also shall specify that the Option is intended to be a nonqualified stock option whose grant is intended not to fall under the provisions of Code Section 422. 
  
 6.3 OPTION PRICE. The Option Price for each grant of an Option under this Plan shall be at
least equal to 100% of the Fair Market Value of a Share on the date the Option is granted. 
  
 6.4 VESTING OF OPTIONS. Unless otherwise designated by the Compensation Committee, each Option granted pursuant to the Plan shall vest as follows: 
  
 (a) 34% of the Options granted shall vest on the Option grant date; 
  
 (b) 33% of the Options granted shall vest on each of the first anniversary
and second anniversary of the Option grant date; provided, however, that if during the first year after the Option grant date, the stock price of the Company’s common stock closes at or above $12.00 for any twenty (20) out of 

 

 9 

 thirty (30) consecutive trading days, the 33% of the Options due to vest on the first anniversary of the Option
grant date shall vest immediately at the end of such 20th day; and, provided further, that if during the second year after the Option grant date, the stock price of the Company’s common stock closes at or above $18.00 for any twenty
(20) out of thirty (30) consecutive trading days, the 33% of Options due to vest on the second anniversary of the Option grant date shall vest immediately at the end of such 20th day. 
  
 6.5 DURATION OF OPTIONS. Each Option granted to an Employee shall expire at such time as the
Committee shall determine at the time of grant; provided, however, that no Option shall be exercisable later than the tenth anniversary date of its grant. 
  
 6.6 EXERCISE OF OPTIONS. Options granted under this Article 6 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall
in each instance approve, which need not be the same for each grant or for each Participant. 
  
 6.7 PAYMENT. Options granted under this Article 6 shall be exercised in accordance with rules and procedures established by the Committee or, in the absence of such rules and procedures, (i) in accordance with
the Award Agreement or (ii) by the delivery of a proper notice of exercise to the Company, setting forth the number of Shares with respect to which the Option is to be exercised. 
  
 No shares of Common Stock shall be issued on the exercise of an Option unless the Option Price is paid for in full at the time of exercise.
Payment shall be made in cash, check in a form acceptable to the Company or other instrument acceptable to the Company. In addition, subject to compliance with applicable laws and regulations and such conditions as the Committee may impose, the
Committee may elect to accept payment in shares of Common Stock of the Company which are already owned by the Participant, valued at the Fair Market Value thereof on the date of exercise. The Committee may also allow a Participant to exercise an
Option by use of proceeds to be received from the sale of Common Stock issuable pursuant to the Option being exercised. Moreover, the Committee, acting in its absolute discretion, may authorize payment in any combination of the foregoing payment
options, and the Committee, acting in its absolute 
  

 10 

 discretion, may, subject to the applicable provisions of Delaware law, elect to accept payment in the form of a note
acceptable to the Committee or in the form of any other property acceptable to the Committee. 
  
 As soon as practicable after receipt of proper notification of exercise and full payment, the Company, if requested by the Participant, shall deliver to the Participant, in the Participant’s name, Share
certificates in an appropriate amount based upon the number of Shares purchased under the Option(s). 
  
 6.8 RESTRICTIONS ON SHARE TRANSFERABILITY. The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of an Option granted under this Article 6 as it may deem advisable, including,
without limitation, restrictions under applicable federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to
such Shares. 
  
 6.9 TERMINATION OF EMPLOYMENT. Except as otherwise provided in an
Award Agreement, any Option, to the extent it has not been previously exercised, shall terminate upon the earliest to occur of: (a) the expiration of the Option period set forth in the Option Award Agreement; (b) the expiration of 12
months following the Participant’s death or Disability; (c) immediately upon termination for Cause; or (d) the expiration of 90 days following the Participant’s termination of employment for any reason other than Cause, Change in
Control, death, Disability. 
  
 6.10 TRANSFERABILITY OF OPTIONS. To the extent not
prohibited by any statute, rule or regulation applicable to the Plan, the Options or the registration with the Securities and Exchange Commission of the Common Stock to be issued upon exercise of the Options, the Committee may, in its discretion,
authorize all or a portion of Options granted to a Participant to be on terms which permit transfer by such Participant to (i) Immediate Family Members, (ii) a trust or trusts for the exclusive benefit of such Immediate Family Members, or
(iii) a partnership in which such Immediate Family Members are the only partners, provided that (A) there may be no consideration for any such transfer, (B) the Award Agreement pursuant to which such Options are granted must be
approved by the Committee, and must expressly provide for transferability in a 
  

 11 

 manner consistent with this Section, and (C) subsequent transfers of transferred Options shall be prohibited except
those by will or the laws of descent and distribution. Following transfer, any such Options shall continue to be subject to the same terms and conditions as were applicable immediately prior to transfer, provided that for purposes of this Plan, the
term “Participant” shall be deemed to refer to the transferee. The events of termination of employment shall continue to be applied with respect to the original Participant, following which the Options shall be exercisable by the
transferee only to the extent, and for the periods specified in this Section 6.9. Notwithstanding the foregoing, should the Committee provide that Options granted be transferable, the Company by such action incurs no obligation to notify or
otherwise provide notice to a transferee of early termination of the Option. In the event of a transfer, as set forth above, the original Participant is and will remain subject to and responsible for any applicable withholding taxes upon the
exercise of such Options. 
  
 ARTICLE 7.
BENEFICIARY DESIGNATION 
  
 A Participant under the Plan may make written
designation of a beneficiary on forms prescribed by and filed with the Corporate Secretary of the Company. Such beneficiary or, if no such designation of any beneficiary has been made, the legal representative of such Participant or such other
person entitled thereto as determined by a court of competent jurisdiction, may exercise, in accordance with and subject to the provisions of Article 6, any unterminated and unexpired Option granted to such Participant to the same extent that the
Participant himself could have exercised such Option were he alive or able; provided, however, that no Option granted under the Plan shall be exercisable for more Shares than the Participant could have purchased thereunder on the date his employment
by, or other relationship with, the Company and its Subsidiaries was terminated. 
  
 ARTICLE 8. RIGHTS OF EMPLOYEES 
  
 8.1 EMPLOYMENT. Nothing in the Plan shall interfere with or limit in any way the right of the Company to terminate any Participant’s employment at any time, nor
confer upon any Participant any right to continue in the employ of the Company. 
  

 12 

 8.2 PARTICIPATION. No Employee shall have the right to be selected to receive an Award under this Plan or, having been so
selected, to be selected to receive a future Award. 
  
 ARTICLE 9. CHANGE IN CONTROL 
  
 9.1 TREATMENT OF OUTSTANDING AWARDS.
Except as may otherwise be provided in the applicable Award Agreement and unless otherwise specifically prohibited under applicable laws, or by the rules and regulations of any governing governmental agencies or national securities exchanges, upon
the occurrence of a Change in Control, any Option granted hereunder shall become immediately exercisable, and shall remain exercisable throughout its term. 
  
 9.2 TERMINATION, AMENDMENT, AND MODIFICATIONS OF CHANGE IN CONTROL PROVISIONS. Notwithstanding any other provision of this Plan or any Award Agreement provision, the
provisions of this Article 9 may not be terminated, amended or modified on or after the date of a Change in Control to affect adversely any Award theretofore granted under the Plan without the prior written consent of the Participant with respect to
said Participant’s outstanding Awards. 
  
 ARTICLE 10. SALE OF BUSINESS UNIT OF COMPANY 
  
 The Committee, in
connection with the sale of any Subsidiary, Affiliate, division or other business unit of the Company, may within the Committee’s sole and absolute discretion cause any or all Options granted hereunder to Participants whose Options or rights
under Options will be adversely affected by such transaction (a) to become immediately exercisable, or (b) to remain exercisable after such transaction for such period as the Committee deems appropriate under the circumstances, or both
(a) and (b). The provisions of this Article 10 and the actions of the Committee taken pursuant to this Article 10 shall be effective upon action of the Committee alone without amendment to any Award Agreement or the consent of any Participant.

  
 ARTICLE 11. AMENDMENT, MODIFICATION, AND
TERMINATION 
  
 11.1 AMENDMENT, MODIFICATION AND TERMINATION. Subject to
Section 9.2 of this Plan, the Board or the Committee may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part. 
  

 13 

 Notwithstanding the foregoing, neither the Company nor the Board or Committee on its behalf may cancel outstanding Awards
and issue substitute Awards in replacement thereof, reduce the exercise price of any outstanding Options or alter the class of participants in the Plan without stockholder approval. 
  
 11.2 ADJUSTMENT OF AWARDS UPON THE OCCURRENCE OF CERTAIN UNUSUAL OR NONRECURRING EVENTS. Subject to Section 9.2 of this Plan, the
Committee may make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in Section 4.2 hereof) affecting the
Company or the financial statements of the Company or of changes in applicable laws, regulations or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of the
benefits or potential benefits intended to be made available under the Plan. 
  
 11.3 AWARDS PREVIOUSLY GRANTED. No termination, amendment or modification of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the written consent of the Participant holding such Award.

  
 ARTICLE 12. WITHHOLDING 
  
 12.1 TAX WITHHOLDING. The Company shall have the power and the right to deduct or withhold
or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes, domestic or foreign, required by law or regulation to be withheld with respect to any taxable event arising as a result of this Plan.

  
 12.2 SHARE WITHHOLDING. To the extent provided by the Committee, a Participant
may elect to have any distribution to be made under this Plan to be withheld or to surrender to the Company shares of Common Stock already owned by the Participant to fulfill any tax withholding obligation. 
  

 14 

 ARTICLE 13. INDEMNIFICATION 
  
 Each person who is or shall have been a member of the Committee, or of the Board, shall be
indemnified and held harmless by the Company against and from any loss, cost, liability or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit or proceeding to which he
or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan and against and from any and all amounts paid by him or her in settlement thereof, with the Company’s approval, or paid
by him or her in satisfaction of any judgment in any such action, suit or proceeding against him or her, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to
handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s Certificate of Incorporation or
Bylaws, as a matter of law or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 
  
 ARTICLE 14. SUCCESSORS 
  
 All obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such
successor is the result of a direct or indirect purchase, of all or substantially all of the business and/or assets of the Company, or a merger, consolidation or otherwise. 
  
 ARTICLE 15. LEGAL CONSTRUCTION 
  
 15.1 GENDER AND NUMBER. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine; the
plural shall include the singular; and, the singular shall include the plural. 
  
 15.2 SEVERABILITY. In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the
illegal or invalid provision had not been included. 
  

 15 

 15.3 REQUIREMENTS OF LAW. The granting of Awards and the issuance of Shares under the Plan shall be subject to all
applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. 
  
 15.4 SECURITIES LAW COMPLIANCE. With respect to Insiders, transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 or its
successors under the Exchange Act. To the extent any provision of the Plan or action by the Committee fails to so comply, it shall be deemed null and void, to the extent permitted by law and deemed advisable by the Committee. 
  
 15.5 GOVERNING LAW. To the extent not preempted by federal law, the Plan, and all agreements
hereunder, shall be construed in accordance with and governed by the laws of the state of Delaware. 
  

 16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00098-of-00352.parquet"}]]